Arcus Biosciences (RCUS) Earnings Report - Discounting Cash Flows
Arcus Biosciences, Inc.
RCUS (NYSE)

* (except for per share items) of USD
Period Ending: 2025
11-04
2025
08-04
2025
05-06
2025
02-19
2024
11-06
2024
08-08
2024
05-08
2024
02-21
2023
11-07
2023
08-07
2023
05-09
2023
02-28
2022
11-02
2022
08-03
2022
05-09
2022
02-23
2021
11-08
2021
08-05
2021
05-05
2021
02-24
2020
11-05
2020
08-06
2020
05-05
2020
03-05
2019
11-05
2019
08-06
2019
05-02
2019
03-05
2018
11-08
2018
08-06
2018
05-09
2017
12-31
2017
09-30
2017
06-30
2017
03-31
Actual EPS - - - - -1.00 -1.02 -0.05 -1.08 -0.94 -1.04 -1.09 -0.93 -0.90 -0.93 -0.96 3.71 -1.11 -1.09 -1.08 -0.82 0.03 -0.93 -0.63 -0.38 -0.51 -0.64 -0.41 -0.28 -0.25 -0.32 -1.37 -0.54 -0.94 -0.39 -0.29
Estimated EPS - - - -1.20 -1.07 -1.02 -0.97 -1.09 -1.12 -1.00 -1.06 -0.99 -1.05 -0.93 0.83 -0.74 -1.13 -0.77 -0.71 -0.62 0.05 -0.54 -0.56 -0.49 -0.47 -0.37 -0.33 -0.44 -0.40 -0.39 -0.88 - - - -
Actual Revenue - - - - 48.0 39.0 145 31.0 32.0 29.0 25.0 0.34 33.6 26.8 18.0 354 9.46 9.46 9.46 9.49 64.5 1.75 1.75 9.75 1.75 1.75 1.75 1.56 4.29 1.25 1.25 1.25 0.16 - -
Estimated Revenue - - - 31.3 29.9 25.6 35.6 28.2 28.3 30.3 25.0 23.3 - - 15.9 95.1 9.37 12.6 12.7 7.93 102 1.15 1.56 13.1 1.68 1.09 1.49 2.45 6.52 1.56 0.91 - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us